Konrad Feichtinger

414 total citations
6 papers, 339 citations indexed

About

Konrad Feichtinger is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Konrad Feichtinger has authored 6 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Konrad Feichtinger's work include Neurotransmitter Receptor Influence on Behavior (4 papers), Chemical Synthesis and Analysis (2 papers) and Psychedelics and Drug Studies (2 papers). Konrad Feichtinger is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (4 papers), Chemical Synthesis and Analysis (2 papers) and Psychedelics and Drug Studies (2 papers). Konrad Feichtinger collaborates with scholars based in United States and China. Konrad Feichtinger's co-authors include Heather L. Sings, Murray Goodman, Christoph W. Zapf, Tracy J. Baker, Kevin Whelan, Graeme Semple, Andrew J. Grottick, Brett R. Ullman, Hussien Al‐Shamma and Carleton R. Sage and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Konrad Feichtinger

6 papers receiving 333 citations

Peers

Countries citing papers authored by Konrad Feichtinger

Since Specialization

Citations

This map shows the geographic impact of Konrad Feichtinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konrad Feichtinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konrad Feichtinger more than expected).

Fields of papers citing papers by Konrad Feichtinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konrad Feichtinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konrad Feichtinger. The network helps show where Konrad Feichtinger may publish in the future.

Co-authorship network of co-authors of Konrad Feichtinger

This figure shows the co-authorship network connecting the top 25 collaborators of Konrad Feichtinger. A scholar is included among the top collaborators of Konrad Feichtinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konrad Feichtinger. Konrad Feichtinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Discovery of a lead series of potent benzodiazepine 5-HT2C receptor agonists with high selectivity in functional and binding assays 2019 ·Bioorganic & Medicinal Chemistry Letters ·Albert Ren, Xiuwen Zhu, Konrad Feichtinger, (unknown), (unknown), Thomas O. Schrader, (unknown), (unknown), (unknown), John Frazer, David J. Unett, Andrew J. Grottick, Kevin Whelan, Michael Morgan, Carleton R. Sage, Graeme Semple	3
2	Tetrahydroquinoline-based tricyclic amines as potent and selective agonists of the 5-HT2C receptor 2016 ·Bioorganic & Medicinal Chemistry Letters ·Thomas O. Schrader, (unknown), Albert Ren, Konrad Feichtinger, (unknown), (unknown), Chunrui Wu, (unknown), (unknown), Joel Gatlin, (unknown), (unknown), Kevin Whelan, Carleton R. Sage, Andrew J. Grottick, Graeme Semple	6
3	Identification of fused bicyclic heterocycles as potent and selective 5-HT2A receptor antagonists for the treatment of insomnia 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Brett R. Ullman, (unknown), (unknown), (unknown), (unknown), Konrad Feichtinger, John Frazer, (unknown), Kevin Whelan, (unknown), Andrew J. Grottick, Hussien Al‐Shamma, Graeme Semple	9
4	Synthesis and in Vivo Evaluation of Phenethylpiperazine Amides: Selective 5-Hydroxytryptamine_2AReceptor Antagonists for the Treatment of Insomnia 2010 ·Journal of Medicinal Chemistry ·Yifeng Xiong, Brett R. Ullman, (unknown), (unknown), (unknown), (unknown), Peter I. Dosa, Konrad Feichtinger, Bradley R. Teegarden, John Frazer, (unknown), Yun Shan, Kevin Whelan, (unknown), Andrew J. Grottick, Graeme Semple, Hussien Al‐Shamma	6
5	Diprotected Triflylguanidines: A New Class of Guanidinylation Reagents 1998 ·The Journal of Organic Chemistry ·Konrad Feichtinger, Christoph W. Zapf, Heather L. Sings, Murray Goodman	185
6	Triurethane-Protected Guanidines and Triflyldiurethane-Protected Guanidines: New Reagents for Guanidinylation Reactions 1998 ·The Journal of Organic Chemistry ·Konrad Feichtinger, Heather L. Sings, Tracy J. Baker, (unknown), Murray Goodman	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact